NEWS
$35m payday for Neuren as blockbuster drug takes off
SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal investors has… read more
Aegros strikes deal for $615m plasma plant in Singapore
SINGAPORE: Aegros has partnered with Cambodia’s Royal Group to build a $US400m ($615m) plasma fractionation… read more
HMC Capital abandons Ingenia land lease communities play
MELBOURNE: David Di Pilla’s HMC Capital is understood to have explored an investment in land… read more
